- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sputum, Cellular Atypia in Brazil
Total 50 results
-
Hospital de Clinicas de Porto AlegreCompletedDeviated Nasal Septum | Nasal Septal Defect | Nasal Septum, IrregularBrazil
-
Hospital Israelita Albert EinsteinUnknownHeadache | Nasal Septum DeviationBrazil
-
Universidade Federal de PernambucoActive, not recruitingAtaxia, CerebellarBrazil
-
Bristol-Myers SquibbCompletedHepato Cellular Carcinoma (HCC)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, ... and more
-
Hospital de Clinicas de Porto AlegreUnknownNatural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD (BIGPRO)Spinocerebellar Ataxia Type 3 | Machado-Joseph DiseaseBrazil
-
Universidade Federal de PernambucoUnknownCerebellar Ataxia | Balance | Cerebellum; InjuryBrazil
-
University of Sao Paulo General HospitalUnknown
-
Laura Alice Santos de OliveiraFederal Institute of Rio de JaneiroEnrolling by invitationGait Ataxia | Postural Balance | SCABrazil
-
Applied Biology, Inc.Jupiter Wellness, Inc.Withdrawn
-
Hospital de Clinicas de Porto AlegreFundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, BrazilWithdrawnSpinocerebellar Ataxia Type 3Brazil
-
University of Sao Paulo General HospitalUnknownCerebellar AtaxiaBrazil
-
Hospital de Clinicas de Porto AlegreRecruitingSpinocerebellar Ataxia Type 3 | Machado-Joseph Disease | SCA3 | MJDBrazil
-
Hospital de Clinicas de Porto AlegreCompletedSpinocerebellar Ataxia Type 3 | Machado Joseph DiseaseBrazil
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Cosmetique Active InternationalCompleted
-
Hospital de Clinicas de Porto AlegreUnknownSpinocerebellar Ataxia Type 3 | Machado-Joseph Disease | SCA3 | MJDBrazil
-
Libbs Farmacêutica LTDACompletedAtopic DermatitisBrazil
-
University of Sao Paulo General HospitalFUNADERSP (Foundation for Research Support of the State of São Paulo)CompletedAtopic DermatitisBrazil
-
University of Sao PauloCompletedAtypical Facial Pain or Atypical OdontalgiaBrazil
-
The Methodist Hospital Research InstituteHospital de Clinicas de Porto AlegreRecruitingSpinocerebellar Ataxia Type 10United States, Brazil
-
Casa Espirita Terra de IsmaelUniversity of Sao PauloCompletedAtopic DermatitisBrazil
-
Farmoquimica S.A.Medcin Instituto da PeleCompletedAtopic DermatitisBrazil
-
Casa Espirita Terra de IsmaelFundação de Amparo à Pesquisa do Estado de São PauloCompletedAtopic Dermatitis | Effects of ImmunotherapyBrazil
-
Monash UniversityChildren's Hospital of Philadelphia; McGill University; University of Florida; University... and other collaboratorsActive, not recruitingFriedreich AtaxiaUnited States, Canada, Australia, Brazil, Germany
-
Azidus BrasilWithdrawn
-
University GhentUniversity of Nottingham; Oswaldo Cruz Foundation; Institut Pasteur; World Health... and other collaboratorsCompletedAscaris Lumbricoides | Ascaris Suum | Trichuris Trichiura | Trichuris Vulpis | Ancylostoma Duodenal | Ancylostoma Caninum | Ancylostoma Ceylanicum | Necator AmericanusArgentina, Australia, Brazil, Cambodia, Cameroon, Ethiopia, Tanzania, Vietnam
-
Galderma Brasil Ltda.Completed
-
PTC TherapeuticsEnrolling by invitationFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
PTC TherapeuticsCompletedFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeBrazil
-
Prof. Dr. Matthis SynofzikRecruitingAtaxiaGermany, Italy, Australia, Brazil, France, New Zealand, Turkey
-
Seelos Therapeutics, Inc.TerminatedSpinocerebellar Ataxia Type 3United States, Spain, Korea, Republic of, Australia, United Kingdom, Brazil, Germany, Portugal
-
Friedreich's Ataxia Research AllianceRecruitingFriedreich AtaxiaUnited States, Canada, New Zealand, Australia, France, Austria, Belgium, Brazil, Czechia, Germany, Greece, Ireland, Italy, Spain, United Kingdom, India, Netherlands
-
SanofiActive, not recruitingDermatitis AtopicAustralia, United States, Argentina, Brazil, Canada, Colombia, France, Mexico, Netherlands
-
AmgenActive, not recruitingAtopic DermatitisKorea, Republic of, United States, Turkey, Hong Kong, United Kingdom, Australia, Brazil, Canada, Argentina
-
SanofiRecruitingDermatitis AtopicItaly, United Kingdom, Argentina, France, Chile, Czechia, Germany, Japan, Spain, China, Netherlands, Brazil, Canada, Denmark, Korea, Republic of, South Africa, Taiwan, Poland, India, Mexico
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisBelgium, Netherlands, Japan, Spain, Switzerland, United Kingdom, Germany, France, Austria, Russian Federation, Poland, Italy, Brazil, Finland
-
Eli Lilly and CompanyIncyte CorporationActive, not recruitingAtopic DermatitisSpain, Taiwan, India, Australia, Poland, Brazil, Austria, Hungary, Japan, Mexico, Germany, Israel, Argentina, France, United Kingdom, Czechia, Russian Federation
-
Eli Lilly and CompanyDermira, Inc.RecruitingEczema | Atopic DermatitisUnited States, Taiwan, Spain, Australia, Mexico, Canada, Germany, Japan, Brazil, Argentina, Poland, Czechia, France
-
Eli Lilly and CompanyRecruitingEczema | Atopic DermatitisUnited States, Taiwan, Spain, Mexico, Japan, Brazil, Australia, Canada, Czechia, France, Germany, Argentina, Poland
-
SanofiRecruitingDermatitis AtopicNorway, Spain, Argentina, Israel, Greece, United States, Australia, Brazil, Canada, China, Colombia, Denmark, France, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation
-
AmgenRecruitingAtopic DermatitisJapan, Korea, Republic of, United States, Taiwan, Spain, Germany, Croatia, China, Greece, Italy, Czechia, Brazil, Poland, Portugal, Slovakia, Argentina, Canada, Puerto Rico, Hungary, Latvia, Netherlands
-
AmgenActive, not recruitingAtopic DermatitisUnited States, Spain, United Kingdom, Korea, Republic of, Australia, Denmark, Germany, Belgium, Canada, Japan, Sweden, Poland, Romania, Estonia, Brazil, Czechia, Portugal, Finland, Mexico, Turkey, South Africa
-
AmgenRecruitingAtopic DermatitisUnited States, Korea, Republic of, Taiwan, Spain, Croatia, China, Greece, Belgium, Thailand, Puerto Rico, Hungary, Poland, Germany, Brazil, Italy, Japan, Canada, France, Romania, Chile
-
AmgenRecruitingAtopic DermatitisUnited States, Japan, Korea, Republic of, Australia, Taiwan, Spain, Switzerland, Germany, Croatia, Austria, Bulgaria, France, Denmark, China, Netherlands, Hungary, Czechia, Poland, Brazil, Greece, Portugal, Italy, Finland, Argentina, Sl... and more
-
PfizerActive, not recruitingDermatitis, AtopicChina, United States, Spain, Taiwan, Germany, Australia, Canada, Hungary, Korea, Republic of, Poland, Serbia, Bulgaria, Czechia, Japan, Latvia, United Kingdom, Belgium, Israel, Italy, Finland, Mexico, Romania, Slovakia, Argentina, Brazil, Chil... and more
-
PfizerCompletedSkin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Genetic Diseases, Inborn | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, AtopicUnited States, Spain, Taiwan, Germany, Canada, China, Poland, Belgium, Serbia, Brazil, Russian Federation, Israel, Latvia, Italy, Romania, Mexico, Argentina, Bulgaria, Chile, Netherlands, Slovakia
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeUnited States, Belgium, China, France, Spain, Canada, South Africa, Japan, Brazil, Italy, Poland, India, Hungary, Mexico, Israel
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeChina, Korea, Republic of, Austria, Taiwan, Greece, Czechia, United States, Japan, Brazil, United Kingdom, India, Slovakia, Slovenia
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeCanada, United States, Japan, France, Spain, Mexico, Peru, Brazil, New Zealand, Belgium, China, Germany, Hungary, Israel, Italy, Poland, South Africa, Turkey, India